Dizal (Jiangsu) Pharmaceutical Co., Ltd. (SHA:688192)
China · Delayed Price · Currency is CNY 48.64
-1.01 (-2.03%)
At close: Mar 20, 2026
SHA:688192 Market Cap
SHA:688192 has a market cap or net worth of 23.07 billion as of March 20, 2026. Its market cap has increased by 23.76% in one year.
Market Cap
23.07B
Enterprise Value
22.21B
Revenue
801.14M
Ranking
n/a
PE Ratio
n/a
Stock Price
48.64
Market Cap Chart
Since December 10, 2021, SHA:688192's market cap has increased from 16.44B to 23.07B, an increase of 40.32%. That is a compound annual growth rate of 8.25%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Mar 19, 2026 | 23.07B | -13.16% |
| Dec 31, 2025 | 26.56B | 54.11% |
| Dec 31, 2024 | 17.24B | -11.74% |
| Dec 29, 2023 | 19.53B | 21.84% |
| Dec 30, 2022 | 16.03B | 7.16% |
| Dec 31, 2021 | 14.96B | -9.01% |
| Dec 10, 2021 | 16.44B | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Hubei Jumpcan Pharmaceutical | 25.55B |
| Kangmei Pharmaceutical | 25.45B |
| Chengdu Kanghong Pharmaceutical Group | 24.55B |
| Zhejiang Huahai Pharmaceutical | 23.20B |
| Jiangsu Nhwa Pharmaceutical Co., LTD | 22.70B |
| Jilin Aodong Pharmaceutical Group | 21.31B |
| Tasly Pharmaceutical Group | 21.06B |
| Apeloa Pharmaceutical Co.,Ltd | 20.50B |